Paldara Pharmaceuticals
PrivateLast Round
Accelerator
Sep 10, 2024
Total Funding Raised
$100,000
Company Overview
Paldara Pharmaceuticals operates in Healthcare & Life Sciences and is based in Stillwater, Oklahoma. Its latest recorded funding round was an Accelerator round in September 2024.
Paldara Pharmaceuticals is a biotechnology company that develops bacteriophage-based therapeutics and advanced hydrogel drug delivery platforms to prevent and treat multidrug-resistant bacterial infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Paldara Pharmaceuticals Comparables
Compare Paldara Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phiogen | 79% | |
| TechnoPhage | 77% | |
| Locus Biosciences | 75% |
For institutional investors. Book with your work email.
Paldara Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 10, 2024 | ||||
| Accelerator | Mar 27, 2024 | ||||
| Accelerator | Jul 13, 2023 | ||||
| Accelerator | May 4, 2023 | ||||
| Grant | Mar 21, 2022 | ||||
Accelerator | Nov 9, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Paldara Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| i2E | Grant |
| Capital Factory | Accelerator |
| gBETA | Accelerator |
| JPMorgan Chase & Co. | Accelerator |
| Oklahoma Center for the Advancement of Science and Technology | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 14, 2025
Developing a hydrogel platform for bacteriophage delivery in collaboration with Mayo Clinic.
- Aug 14, 2025
Partnering with Mayo Clinic on a novel hydrogel drug delivery system.
For institutional investors. Book with your work email.
Paldara Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Paldara Pharmaceuticals's valuation, stock price, and market status.
Is Paldara Pharmaceuticals a public or private company?
Paldara Pharmaceuticals is a private company.
What is the current stock price of Paldara Pharmaceuticals?
Paldara Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Paldara Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Paldara Pharmaceuticals worth (valuation)?
Valuation information for Paldara Pharmaceuticals is not publicly available.
Can I buy Paldara Pharmaceuticals stock?
Paldara Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Paldara Pharmaceuticals's last funding round?
Paldara Pharmaceuticals's most recent funding round was Accelerator on September 10, 2024.
Who are the main investors in Paldara Pharmaceuticals?
Key investors in Paldara Pharmaceuticals include Capital Factory.
Will Paldara Pharmaceuticals IPO soon?
No public IPO plans have been announced for Paldara Pharmaceuticals.
How can I track Paldara Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Paldara Pharmaceuticals's shares on secondary markets.